biotin and fondaparinux
biotin has been researched along with fondaparinux in 6 studies
Compound Research Comparison
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (fondaparinux) | Trials (fondaparinux) | Recent Studies (post-2010) (fondaparinux) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 1,190 | 112 | 559 |
Protein Interaction Comparison
| Protein | Taxonomy | biotin (IC50) | fondaparinux (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 0.011 |
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| de Kort, M; Dubreucq, G; Meuleman, D; Motte, V; Nancy-Portebois, V; Petitou, M; van Boeckel, CA; Vogel, GM; Wisse, JA | 1 |
| Harenberg, J | 1 |
| Buerke, M; Drouget, L; Hauroeder, B; Kaeberich, A; Krezel, C; Maedgefessel, L; Neuhart, E; Raaz, U; Schlitt, A; Vogt, A; Werdan, K | 1 |
| Driguez, PA; Potier, P; Trouilleux, P | 1 |
| Alame, G; Freund, M; Gachet, C; Hechler, B; Magnenat, S; Mangin, PH; Petitou, M; Riehl, N | 1 |
| Brandao, GM; Junqueira, DR; Rollo, HA; Sobreira, ML | 1 |
Reviews
4 review(s) available for biotin and fondaparinux
| Article | Year |
|---|---|
From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
Topics: Animals; Anticoagulants; Antithrombin III; Avidin; Binding Sites; Biotin; Drug Design; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparin Antagonists; Humans; Molecular Structure; Oligosaccharides; Polysaccharides; Rabbits; Structure-Activity Relationship; Thrombosis | 2009 |
Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
Topics: Animals; Anticoagulants; Antithrombin III; Atrial Fibrillation; Avidin; Biotin; Carbohydrate Conformation; Carbohydrate Sequence; Drug Design; Drug Evaluation, Preclinical; Fondaparinux; Hemorrhage; Heparin Antagonists; Humans; Molecular Sequence Data; Molecular Structure; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thrombosis; Treatment Outcome | 2009 |
Synthetic oligosaccharides as active pharmaceutical ingredients: lessons learned from the full synthesis of one heparin derivative on a large scale.
Topics: Biotin; Fondaparinux; Heparin; Molecular Structure; Oligosaccharides; Polysaccharides; Structure-Activity Relationship | 2014 |
Pentasaccharides for the treatment of deep vein thrombosis.
Topics: Anticoagulants; Biotin; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Venous Thrombosis | 2017 |
Trials
1 trial(s) available for biotin and fondaparinux
| Article | Year |
|---|---|
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Biotin; Cardiac Catheters; Enoxaparin; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Male; Middle Aged; Oligosaccharides; Polysaccharides; Prothrombin; Thrombosis | 2014 |
Other Studies
1 other study(ies) available for biotin and fondaparinux
| Article | Year |
|---|---|
EP217609, a neutralisable dual-action FIIa/FXa anticoagulant, with antithrombotic effects in arterial thrombosis.
Topics: Animals; Anticoagulants; Arteries; Avidin; Biotin; Bleeding Time; Blood Coagulation; Dose-Response Relationship, Drug; Factor Xa; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligosaccharides; Polysaccharides; Prothrombin; Thrombosis | 2015 |